PERCHERON

Serial Number 79392666
Registration 7862415
700

Registration Progress

Application Filed
Mar 4, 2024
Under Examination
Approved for Publication
May 27, 2025
Published for Opposition
May 27, 2025
Registered
Jul 15, 2025

Trademark Image

PERCHERON

Basic Information

Serial Number
79392666
Registration Number
7862415
Filing Date
March 4, 2024
Registration Date
July 15, 2025
Published for Opposition
May 27, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 15, 2025
Registration
Registered
Classes
005 035 042

Rights Holder

Percheron Therapeutics Limited

83
Address
Level 30, 35 Collins Street
Melbourne VIC 3000
AU

Ownership History

Percheron Therapeutics Limited

Original Applicant
83
AU

Percheron Therapeutics Limited

Owner at Publication
83
AU

Percheron Therapeutics Limited

Original Registrant
83
AU

Legal Representation

Attorney
Frederick H. Colen

USPTO Deadlines

Next Deadline
2006 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250715)
Due Date
July 15, 2031
Grace Period Ends
January 15, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Oct 30, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 15, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Sep 27, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Sep 18, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Aug 27, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Aug 27, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jul 15, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 15, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 27, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 27, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 21, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 23, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 24, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 24, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 24, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 21, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 21, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 21, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 19, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Oct 2, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Oct 2, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 28, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 27, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 26, 2024 RFWR P NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Loading...
Sep 22, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 21, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 18, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 6, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 2, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 28, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of rare neurological diseases and cancer, excluding pharmaceuticals for horses and pharmaceuticals for the treatment of an artery of Percheron
Class 035
Business intermediary services relating to the commercializing of goods, namely, negotiation of commercial transactions for third parties in the field of pharmaceuticals
Class 042
Scientific research in the nature of conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others; biotechnology research, namely, biotechnology testing; scientific research relating to pharmaceuticals; pharmaceutical research services; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals; services for assessing the safety of pharmaceuticals, namely, testing of pharmaceuticals; all of the aforesaid excluding services for the treatment of an artery of Percheron

Classification

International Classes
005 035 042